Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19095572rdf:typepubmed:Citationlld:pubmed
pubmed-article:19095572lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:19095572lifeskim:mentionsumls-concept:C0699791lld:lifeskim
pubmed-article:19095572lifeskim:mentionsumls-concept:C1704242lld:lifeskim
pubmed-article:19095572lifeskim:mentionsumls-concept:C0026682lld:lifeskim
pubmed-article:19095572lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:19095572lifeskim:mentionsumls-concept:C0334037lld:lifeskim
pubmed-article:19095572lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:19095572lifeskim:mentionsumls-concept:C1519104lld:lifeskim
pubmed-article:19095572lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:19095572lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:19095572lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:19095572pubmed:issue1lld:pubmed
pubmed-article:19095572pubmed:dateCreated2008-12-19lld:pubmed
pubmed-article:19095572pubmed:abstractTextOur aim was to evaluate the usefulness of the monoclonal antibody Das-1 as a premalignant marker of gastric intestinal metaplasia (GIM) associated with gastric cancer and its association with mucin expression. We evaluated Das-1 and mucin expression in 4 groups: 1 (n = 50), gastric carcinoma, paired samples of the cancer area and GIM away from the tumor; 2 (n = 25), gastric or duodenal ulcer with Helicobacter pylori infection with GIM and chronic gastritis; 3 (n = 25),H pylori- autoimmune chronic atrophic gastritis with GIM; and 4 (n = 25),H pylori- chronic gastritis without GIM. Das-1 immunostaining was observed in 20 (40%) of 50 cases in cancer areas. The expression of Das-1 in GIM from group 1 cases away from the cancer area was different from that in GIM from nontumor cases (groups 2 and 3): 13 (26%) of 50 vs 2 (8%) and 0 (0%) of 25 (P = .004). There was no association between Das-1 and mucin expression. Das-1 expression was associated with GIM from patients with gastric cancer. However, this relation was weaker than previously reported, precluding clinical usefulness as a premalignant marker of GIM.lld:pubmed
pubmed-article:19095572pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19095572pubmed:languageenglld:pubmed
pubmed-article:19095572pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19095572pubmed:citationSubsetAIMlld:pubmed
pubmed-article:19095572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19095572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19095572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19095572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19095572pubmed:statusMEDLINElld:pubmed
pubmed-article:19095572pubmed:monthJanlld:pubmed
pubmed-article:19095572pubmed:issn1943-7722lld:pubmed
pubmed-article:19095572pubmed:authorpubmed-author:SalasAntonioAlld:pubmed
pubmed-article:19095572pubmed:authorpubmed-author:RosinachMercè...lld:pubmed
pubmed-article:19095572pubmed:authorpubmed-author:CasalotsJaume...lld:pubmed
pubmed-article:19095572pubmed:authorpubmed-author:Garcia-GilL...lld:pubmed
pubmed-article:19095572pubmed:authorpubmed-author:Fernández-Bañ...lld:pubmed
pubmed-article:19095572pubmed:authorpubmed-author:EsteveMariaMlld:pubmed
pubmed-article:19095572pubmed:authorpubmed-author:EspinósJorgeJlld:pubmed
pubmed-article:19095572pubmed:authorpubmed-author:FornéMontserr...lld:pubmed
pubmed-article:19095572pubmed:authorpubmed-author:LorasCarmeClld:pubmed
pubmed-article:19095572pubmed:authorpubmed-author:González-Míng...lld:pubmed
pubmed-article:19095572pubmed:authorpubmed-author:Poblet-MasNúr...lld:pubmed
pubmed-article:19095572pubmed:authorpubmed-author:ViverJosep...lld:pubmed
pubmed-article:19095572pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19095572pubmed:volume131lld:pubmed
pubmed-article:19095572pubmed:ownerNLMlld:pubmed
pubmed-article:19095572pubmed:authorsCompleteYlld:pubmed
pubmed-article:19095572pubmed:pagination99-105lld:pubmed
pubmed-article:19095572pubmed:dateRevised2010-5-17lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:meshHeadingpubmed-meshheading:19095572...lld:pubmed
pubmed-article:19095572pubmed:year2009lld:pubmed
pubmed-article:19095572pubmed:articleTitleLack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia.lld:pubmed
pubmed-article:19095572pubmed:affiliationDepartment of Gastroenterology, Hospital Universitari Mútua Terrassa, Terrassa, Spain.lld:pubmed
pubmed-article:19095572pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19095572pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19095572lld:pubmed